Pomerantz LLP Investigates Potential Claims Involving Anika Therapeutics Investors

A law firm has initiated an investigation into potential claims on behalf of investors in Anika Therapeutics, Inc. (NASDAQ: ANIK), according to a statement released on September 3, 2025. Pomerantz LLP announced it is examining possible issues related to the company that may have impacted shareholders. The firm is encouraging affected investors to reach out for further information.

The announcement invites individuals who have invested in Anika Therapeutics to contact Danielle Peyton at Pomerantz LLP via email at [email protected] or by phone at 646-581-9980, extension 7980. No additional details about the nature of the claims or the scope of the investigation were disclosed in the initial statement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: September 3, 2025

Author

Mark Chiang